These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1085534)

  • 1. [The antithrombotic treatment and prevention of recurrence with acetylsalicylic acid in myocardial infarct].
    Heuchel G; Hässler W
    Z Gesamte Inn Med; 1976 Feb; 31(3):61-5. PubMed ID: 1085534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experiences from general practice: use of acetylsalicylic acid and anticoagulants in patients following acute myocardial infarct].
    Dahn G; Kothe K
    Z Gesamte Inn Med; 1990 Aug; 45(15):439-41. PubMed ID: 2247990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Platelet antiaggregants or anticoagulants in the secondary prevention after myocardial infarct].
    Di Pasquale G; Ottani F; Ceré E; Biancoli S; Sassone B; Lombardi A
    Recenti Prog Med; 1998 Oct; 89(10):514-9. PubMed ID: 9842255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anticoagulants and thrombocyte aggregation inhibitors in the treatment of heart infarct. A survey].
    Spitzer W; Durst OE; Lang E
    Fortschr Med; 1983 Jan; 101(1-2):22-30. PubMed ID: 6826125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Summary: Secondary prophylaxis following myocardial re-infarct. Anticoagulants or thrombocyte function inhibitors?].
    Breddin K; Loeliger EA
    Internist (Berl); 1980 Jul; 21(7):399. PubMed ID: 7007281
    [No Abstract]   [Full Text] [Related]  

  • 6. A cost-effectiveness analysis of aspirin versus oral anticoagulants after acute myocardial infarction in Italy -- equivalence of costs as a possible case for oral anticoagulants.
    Gianetti J; Gensini G; De Caterina R
    Thromb Haemost; 1998 Dec; 80(6):887-93. PubMed ID: 9869155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anticoagulants or thrombocyte aggregation inhibitors in the prevention of recurrent heart infarction?].
    Volger E; Theiss W
    MMW Munch Med Wochenschr; 1983 Apr; 125(14):285-8. PubMed ID: 6406866
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
    Arjomand H; Cohen M; Ezekowitz MD
    J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Second prevention following myocardial infarct].
    Burkart F
    Schweiz Med Wochenschr; 1984 Jan; 114(3):104-7. PubMed ID: 6142527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Platelet aggregation inhibitor in general practice. Every 3rd infarct prevented--reinfarction rate cut in half].
    Fliri M
    MMW Fortschr Med; 2002 Aug; 144(33-34):38-41. PubMed ID: 12380142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complications of antithrombotic prophylaxis with acetylsalicylic acid (ASS) in polycythemia (author's transl)].
    Ranft K; Brands W
    Med Klin; 1978 Jun; 73(22):839-42. PubMed ID: 307109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Secondary prevention after acute myocardial infarction: aspirin, warfarin or both?].
    Reikvam A; Madsen S; Landmark K
    Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1838-40. PubMed ID: 12830258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anticoagulant or antiaggregant therapy in the secondary prevention of myocardial infarct?].
    De Caterina R; Gianetti J; Simonetti I; Gensini G
    G Ital Cardiol; 1996 Nov; 26(11):1309-21. PubMed ID: 9036028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The rate of acetylsalicylic acid non-respondents among patients hospitalized for acute coronary disease, previously undergoing secondary salicylic acid prophylaxis].
    Tarján J; Salamon A; Jáger R; Poór F; Barczi V; Dinnyés J; Hamvas J; Kinczel A; Pál A; Blaskó G
    Orv Hetil; 1999 Oct; 140(42):2339-43. PubMed ID: 10560261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
    Sarasin FP; Bounameaux H
    Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of antithrombotic agents after myocardial infarction].
    Castaigne A; Albo C; Verschuren P; Perchet H; Pham I; Saal JP
    Arch Mal Coeur Vaiss; 1992 Nov; 85(11 Suppl):1703-8. PubMed ID: 1304143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fixed low-dose warfarin added to aspirin in the long term after acute myocardial infarction; the LoWASA Study.
    Herlitz J; Holm J; Peterson M; Karlson BW; Haglid Evander M; Erhardt L;
    Eur Heart J; 2004 Feb; 25(3):232-9. PubMed ID: 14972424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interference in platelet-fibrinogen system for prevention and therapy of myocardial infarct].
    van de Loo J
    Dtsch Med Wochenschr; 1982 Jan; 107(2):66-70. PubMed ID: 7035118
    [No Abstract]   [Full Text] [Related]  

  • 19. [Secondary prevention of myocardial infarct. Evaluation of a 2-year trial comparing acetylsalicylic acid to oral anticoagulants].
    Rev Prat; 1978 Jan; 28(1):43-56. PubMed ID: 635389
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acetylsalicylic acid after myocardial infarct].
    Sinzinger H; Kritz H
    Wien Klin Wochenschr; 1997; 109 Suppl 2():25-8. PubMed ID: 9340919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.